Overview, China, vaccines, U.S developments

Factbox: Latest on the worldwide spread of the coronavirus China sent the military and thousands of healthcare workers into Shanghai to help carry out COVID-19 tests for its 26 million residents as cases continued to rise on Monday, in one of the country's biggest-ever public health responses. Reuters Reuters

April 4 (Reuters) - China sent the military and thousands of healthcare workers into Shanghai to help carry out COVID-19 tests for its 26 million residents as cases continued to rise on Monday, in one of the country's biggest-ever public health responses. read more

* Shanghai ordered its 26 million residents to undergo two more rounds of tests for COVID-19 as public anger grows over how authorities in China's most populous city are tackling a record coronavirus surge. read more

* A recent rise in Taiwan's domestic COVID-19 cases will not affect plans to gradually re-open as hardly any of the new infections have caused serious illness, Premier Su Tseng-chang said. read more  ...

* Italy reported 53,588 COVID-19 related cases on Sunday, against 70,803 the day before, the health ministry said, while the number of deaths fell to 118 from 129.

* Brazilian health agency Anvisa issued a new set of rules for incoming international travelers, easing restrictions related to the COVID-19 pandemic as the health crisis subsides in the South American nation. read more

* Facebook-owner Meta (FB.O) is no longer requiring employees to have COVID-19 boosters to enter its offices in the United States, a company spokesperson said. read more

* Roche (ROG.S) said the U.S. Food and Drug administration granted priority review to its Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults. read more

* The World Health Organization said it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection. read more

* Chinese vaccine developer CanSino Biologics Inc said on Monday its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical products regulator to enter clinical trials. read more

...